Glipizide Tablets
Company: Duramed PharmaceuticalsApproval Status: Approved September 1997
Treatment for: diabetes
Areas: Diabetes / Endocrinology
General Information
The U.S. Food and Drug Administration has authorized Duramed Pharmaceuticals, Inc. to market Glipizide Tablets, a treatment for diabetes, in the 5 mg and 10 mg strengths. The FDA granted Duramed's Glipizide tablets a therapeutic equivalency rating of AB, designating Duramed's Glipizide tablets as completely interchangeable with Glucotrol (R) tablets for all new and refill prescriptions.
Glipizide Tablets Drug Information
The Glipizide Tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
